MedPath

Effectiveness of a Self-management App in Improving the Control of Asthma Among School Adolescents

Not Applicable
Not yet recruiting
Conditions
Asthma
Interventions
Device: The KmAsthma self-management smart phone app intervention
Registration Number
NCT05850806
Lead Sponsor
Makerere University
Brief Summary

Uganda experiences high morbidity and costs due to uncontrolled asthma. Poor asthma control in adolescents is partly attributed to inadequate asthma education; indicating that education and self-management programs are essential components of asthma control. Adolescents with poorly controlled asthma are reported to have improved asthma control after using a smart phone application in outpatient setting studies. However, there is paucity of data on the effectiveness, feasibility and acceptability of smart phone applications in the control of asthma among adolescent secondary school students in low resource settings.

Detailed Description

Uganda experiences high morbidity and costs due to uncontrolled asthma. Poor asthma control in adolescents is partly attributed to inadequate asthma education; indicating that education and self-management programs are essential components of asthma control. Adolescents with poorly controlled asthma are reported to have improved asthma control after using a smart phone application in outpatient setting studies. However, there is paucity of data on the effectiveness, feasibility and acceptability of smart phone applications in the control of asthma among adolescent secondary school students in low resource settings. This study will evaluate the effectiveness, acceptability and feasibility of the "KmAsthma" self-management app in improving the control of asthma among day scholar secondary school adolescents in Kampala City Uganda.

This study is a 6-month cluster randomized, controlled, single-centre, single-blinded, pragmatic parallel trial, with two arms and a primary endpoint of improving the control of uncontrolled asthma measured as change in individual mean scores on the Asthma control questionnaire during a self-management intervention delivered by the "KmAsthma" smartphone app. The study will compare students with uncontrolled asthma in the intervention group using the "KmAsthma" smartphone app (T) with the students in the control arm (C) who will receive no intervention. Data will be analysed by summarizing descriptive statistics; determining odds ratios for asthma control using logistic regression models, using repeated measures ANCOVA for repeated continuous measurements. Permission from CEU and approval from SOMREC and UNCST will be sought. Informed and written consent and assent will sought. Dissemination will be through publications and presentations in local and international conferences. The findings may contribute to filling the gap leading to overall unsatisfactory asthma control in adolescents.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
66
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
KmAsthma self-management smart phone app interventionThe KmAsthma self-management smart phone app interventionParticipants assigned to the intervention arm will be given a link to download the self-management app on their Android smartphone or iPhone
Primary Outcome Measures
NameTimeMethod
Change in mean Asthma Control Test (ACT) scoresBaseline, 3 and 6 months

The ACT questionnaire is composed of five questions, each scored on a scale from 1 to 5, with a total score range of 5 to 25. A score of 19 or above is considered indicative of well-controlled asthma

Secondary Outcome Measures
NameTimeMethod
Adolescent Asthma Self-Efficacy Questionnaire (AASEQ)Baseline, 3 and 6 months

Change in AASEQ scores

Feasibility based on proportion of participants that will drop out of the studyBaseline, 3 and 6 months

Deemed feasible if the percentage of participants who drop out of the study (i.e., fail to complete any of the tools) is less than 15%

© Copyright 2025. All Rights Reserved by MedPath